How much funding has BenevolentAI raised?

BenevolentAI has raised $115.0M in total funding, most recently a Venture Round.

Who are BenevolentAI's investors?

BenevolentAI's investors include Woodford Investment Management.

When was BenevolentAI founded?

BenevolentAI was founded in 2013.

Where is BenevolentAI headquartered?

BenevolentAI is headquartered in London, United Kingdom.

What industry is BenevolentAI in?

BenevolentAI operates in Drug Discovery, Artificial Intelligence, Biotech, Healthcare.

How many employees does BenevolentAI have?

BenevolentAI has 201-500 employees.

BenevolentAI

Life science intelligence at your fingertips

London, United Kingdom · Founded 2013 · $115.0M raised

Drug Discovery

Artificial Intelligence

Biotech

Healthcare

Headquarters: London
Employees: 201–500
Founded: 2013
Business Model: B2B

Website: benevolent.com
Total Funding: $115.0M
Last Round: $115.0M Venture RoundApr 2018
Rounds: 1

About

BenevolentAI is a clinical-stage, AI-enabled drug discovery and development company listed on Euronext Amsterdam. Founded in 2013, the company uses its proprietary Benevolent Platform — built on a decade of investment in knowledge graphs and ontologies — to integrate life science data and augment scientific decision-making. Headquartered in London with offices in Cambridge and New York, BenevolentAI partners with pharmaceutical companies and pursues its own pipeline for complex diseases.

Summary

BenevolentAI is a Drug Discovery company based in London, United Kingdom, founded in 2013. It has raised $115.0M in total across 1 round, most recently a $115.0M Venture Round round in Apr 2018. Investors include Woodford Investment Management.

LinkedIn X (Twitter)GitHub